Integral Ad Science Holding Corp.

NASDAQ:IAS

9.92 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 133.528129.005114.53134.295120.331113.651106.092117.435101.343100.32889.242102.47279.01475.07566.95278.30759.96448.3254.042
Cost of Revenue 27.37327.09441.24142.84525.59923.81921.68221.89119.17118.13216.56116.38113.84612.92511.4212.41510.188.7569.155
Gross Profit 106.155101.91173.28991.4594.73289.83284.4195.54482.17282.19672.68186.09165.16862.1555.53265.89249.78439.56444.887
Gross Profit Ratio 0.7950.790.640.6810.7870.790.7960.8140.8110.8190.8140.840.8250.8280.8290.8410.830.8190.831
Reseach & Development Expenses 16.8417.48717.97819.05617.21121.1115.52922.2819.45917.62416.98719.46514.60920.17612.76912.82211.10712.72612.336
General & Administrative Expenses 25.34824.67921.3825.96122.61142.33920.72323.57220.1519.13716.76921.52516.08933.0448.54710.8376.8637.9467.64
Selling & Marketing Expenses 30.14429.57231.82530.42329.60431.70226.2628.32528.1926.69123.05723.45419.57427.26816.54517.37913.51916.75418.37
SG&A 55.49254.25153.07955.3352.21574.04146.98351.89748.3445.82839.82644.97935.66360.31225.09228.21620.38224.726.01
Other Expenses 13.63616.02416.64914.09216.10512.8912.82512.8116.98112.5112.45817.18816.114.60314.39516.52316.43416.41316.338
Operating Expenses 85.96887.76271.05774.38683.453108.67275.33786.98880.41675.96269.27181.63266.37295.09152.25657.56147.92353.83954.684
Operating Income 20.18714.1492.23217.0649.201-18.2099.5897.31-2.3086.7463.41-2.141-1.204-32.9413.2768.3311.861-14.275-9.797
Operating Income Ratio 0.1510.110.0190.1270.076-0.160.090.062-0.0230.0670.038-0.021-0.015-0.4390.0490.1060.031-0.295-0.181
Total Other Income Expenses Net -1.325-1.536-1.926-2.489-3.109-3.221-3.417-3.1944.362-1.814-1.426-1.364-9.474-5.167-6.96-7.822-7.795-7.695-8.258
Income Before Tax 18.86212.613-1.38914.0226.092-21.436.1724.1162.0544.9321.984-3.505-10.678-38.108-3.6840.509-5.934-21.97-18.055
Income Before Tax Ratio 0.1410.098-0.0120.1040.051-0.1890.0580.0350.020.0490.022-0.034-0.135-0.508-0.0550.007-0.099-0.455-0.334
Income Tax Expense 2.7734.923-0.1343.85819.841-29.1073.026-7.3711.2872.9710.8251.317-0.898-3.045-0.912-2.46-1.486-5.519-3.611
Net Income 16.0897.69-1.25510.164-13.7497.6773.14611.4860.7671.9611.159-4.822-9.78-35.063-2.7722.969-4.448-16.451-14.444
Net Income Ratio 0.120.06-0.0110.076-0.1140.0680.030.0980.0080.020.013-0.047-0.124-0.467-0.0410.038-0.074-0.34-0.267
EPS 0.10.048-0.0080.064-0.0880.0490.020.0750.0050.010.008-0.032-0.064-0.26-0.0190.022-0.033-0.12-0.097
EPS Diluted 0.0980.047-0.0080.062-0.0880.0470.020.0740.0050.010.007-0.032-0.064-0.26-0.0190.022-0.033-0.12-0.097
EBITDA 36.4331.22117.31231.65725.306-4.68821.89820.1221.35418.74415.86815.04711.175-18.33817.67124.85418.2952.1386.541
EBITDA Ratio 0.2730.2420.1510.2360.21-0.0470.2060.1820.2110.1870.1780.2110.189-0.2440.2640.3170.3050.0440.121